Baker Brothers Advisors - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 37 filers reported holding ATYR PHARMA INC in Q4 2022. The put-call ratio across all filers is 12.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q4 2022$18,757
-96.9%
8,565
-95.7%
0.00%
-100.0%
Q3 2022$604,000
-43.0%
201,361
-46.2%
0.00%
-33.3%
Q2 2022$1,060,000
-68.3%
374,395
-40.1%
0.01%
-68.4%
Q1 2022$3,344,000
-28.4%
625,0000.0%0.02%
-17.4%
Q4 2021$4,669,000
-17.7%
625,0000.0%0.02%
-8.0%
Q3 2021$5,675,000625,0000.02%
Other shareholders
ATYR PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,626,624$7,310,0662.43%
Tikvah Management LLC 2,460,833$3,888,1161.40%
TANG CAPITAL MANAGEMENT LLC 471,134$744,3920.10%
FEDERATED HERMES, INC. 10,169,600$16,067,9680.04%
Alyeska Investment Group, L.P. 2,455,555$3,879,7770.03%
XTX Topco Ltd 73,894$116,7530.02%
ALTERNA WEALTH MANAGEMENT, INC 10,000$15,8000.02%
Pale Fire Capital SE 55,857$88,2540.01%
GSA CAPITAL PARTNERS LLP 27,559$440.00%
Virtu Financial LLC 13,662$220.00%
View complete list of ATYR PHARMA INC shareholders